🔎 Trials Near Me

Dachaigh › Ailseachadh an Ae › Texas

Sgrùdaidhean clionaigeach Ailseachadh an Ae ann an Texas

Tha 24 sgrùdaidhean airson Ailseachadh an Ae a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

DESTINY-PANTUMOUR04

  • Research Site, Dallas
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07124000

National Liver Cancer Screening Trial

  • UT Southwestern Medical Center and Parkland Hospital, Dallas
  • Baylor College of Medicine, Houston
A’ fastadhÌre 4
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06084234

CREO - Microwave Ablation Feasibility Study

  • Memorial Hermann-Texas Medical Center, Houston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07817147

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  • St. David's Medical Center, Austin
A’ fastadhSgrùdadh amharc
Aoisean 22 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06486454

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

  • University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT04864054

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • UT MD Anderson, Houston
  • NEXT Oncology, San Antonio
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06440005

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

  • Texas Children's Hospital, Houston
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT04715191

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

  • MD Anderson Cancer Center, Houston
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07010315

Multi-analyte Blood Test Clinical Trial

  • South Texas Research Institute, Edinburg
  • Texas Gastro Research, El Paso
  • Impact Research Institute, Waco
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT05199259

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

  • NEXT Dallas, Dallas
  • MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07337525

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • JPS Health Network, Forth Worth
  • Baylor Scott and White Biorepository, Temple
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT07327489

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

  • Clinical Trial Site, Dallas
  • Clinical Trial Site, Houston
  • Clinical Trial Site, San Antonio
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT06600321

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A’ fastadh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT05486572

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

  • START Dallas, Fort Worth
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT07517198

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06239194

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

  • MD Anderson Cancer Center, Houston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06362369

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

  • Md Anderson Cancer Center, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT04075305

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

  • Baylor College of Medicine, Houston
A’ fastadhÌre 2
Aoisean 0 gu 30 · Gach gnè · Air ùrachadh 24 Gearr 2026 · NCT04134559

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

  • NEXT Dallas, Dallas
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Faoi 2026 · NCT07317505

Sample Collection for Ongoing Research and Product Evaluation Study

  • Natera, Inc., Austin
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Faoi 2026 · NCT07318051

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Dallas
  • Massive Bio SYNERGY-AI site, Houston
  • Massive Bio SYNERGY-AI site, Temple
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

EGCG for Hepatocellular Carcinoma Chemoprevention

  • UT Southwestern, Dallas
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Sult 2025 · NCT06015022

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

  • Site 881, Dallas
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Gibl 2025 · NCT05201404

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

  • Houston Methodist Research Institute, Houston
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Gearr 2023 · NCT05185505

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.